NM_001122955.3:c.509_513delATCGT

Subject ID	Country of Origin	Allele Count	CTGA Clinical Significance	Condition(s)	Reference	Remarks
269700.1	Lebanon	2	Pathogenic	Lipodystrophy, Congenital Generalized, Type 2	Magre et al. 2001
269700.2	Lebanon	2	Pathogenic	Lipodystrophy, Congenital Generalized, Type 2	Magre et al. 2001
269700.3	Lebanon	2	Pathogenic	Lipodystrophy, Congenital Generalized, Type 2	Magre et al. 2001
269700.4	Lebanon	2	Pathogenic	Lipodystrophy, Congenital Generalized, Type 2	Magre et al. 2001
269700.5	Lebanon	2	Pathogenic	Lipodystrophy, Congenital Generalized, Type 2	Magre et al. 2001
269700.6	Lebanon	2	Pathogenic	Lipodystrophy, Congenital Generalized, Type 2	Agarwal et al. 2003
269700.7.1	Lebanon	2	Pathogenic	Lipodystrophy, Congenital Generalized, Type 2	Agarwal et al. 2003	First cousin once removed of 269700.7.2 ...
269700.7.2	Lebanon	2	Pathogenic	Lipodystrophy, Congenital Generalized, Type 2	Agarwal et al. 2003	Sibling of 269700.7.3 and first cousin o...
269700.7.3	Lebanon	2	Pathogenic	Lipodystrophy, Congenital Generalized, Type 2	Agarwal et al. 2003	Sibling of 269700.7.2 and first cousin o...
269700.8	Lebanon	2	Pathogenic	Lipodystrophy, Congenital Generalized, Type 2	Agarwal et al. 2003
269700.9	Lebanon	2	Pathogenic	Lipodystrophy, Congenital Generalized, Type 2	Agarwal et al. 2003
269700.G.1	Lebanon	42	Pathogenic	Lipodystrophy, Congenital Generalized, Type 2	Van Maldergem et al. 2002	Group of 21 patients from 6 families

Epidemiology in the Arab World